109 results
Page 2 of 6
8-K
EX-99.1
6chxcoe7mo
4 Nov 21
Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
4:18pm
8-K
EX-99.1
svsq1twhw74fc6 8jjg
5 Aug 21
Prothena Reports Second Quarter 2021 Financial Results and Business Highlights
4:11pm
8-K
jrvyuec8b cvszrm
12 Jul 21
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
8:57am
424B5
rfeov2b3
28 May 21
Prospectus supplement for primary offering
5:09pm
8-K
EX-99.1
fvg2msud736
11 May 21
Prothena Reports First Quarter 2021 Financial Results, and Provides Updated Financial Guidance and R&D Update
4:07pm
DEFA14A
s3bejq6v4oc9kk2t 53f
31 Mar 21
Additional proxy soliciting materials
4:16pm
424B5
38ff092nre9diuk
24 Mar 21
Prospectus supplement for primary offering
4:01pm
424B5
m0iq24jlg7s69ln2wj
23 Mar 21
Prospectus supplement for primary offering
5:13pm
SC TO-I/A
r18ef5 6pt2mjvq7
16 Feb 21
Issuer tender offer statement (amended)
5:01pm
SC TO-I/A
a9jvnfw1xv60t4
28 Jan 21
Issuer tender offer statement (amended)
5:02pm
SC TO-I/A
09c4r01qr
21 Jan 21
Issuer tender offer statement (amended)
5:01pm
SC TO-I/A
ypyolg qdfu5bm2n
4 Dec 20
Issuer tender offer statement (amended)
5:01pm
SC TO-I
6vzoak 01qgy57ij
9 Nov 20
Issuer tender offer statement
9:01am